Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IDYA
IDYA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IDYA News
IDEAYA Biosciences Reports Q1 2026 Financial Results and Business Update
6d ago
PRnewswire
IDEAYA Grants Stock Options to New Employees
May 01 2026
PRnewswire
IDEAYA Grants 237,800 Stock Options to New Employees
May 01 2026
Newsfilter
IDEAYA Biosciences to Present Key Data at ASCO Meeting
Apr 21 2026
PRnewswire
IDEAYA Biosciences Announces Key Clinical Data Presentation
Apr 21 2026
Newsfilter
U.S. Stocks Close Higher, Led by Tech Sector Gains
Apr 13 2026
NASDAQ.COM
Mixed US Stock Performance Amid Soaring Oil Prices
Apr 13 2026
NASDAQ.COM
Oil Price Surge Triggers Market Volatility
Apr 13 2026
NASDAQ.COM
IDEAYA and Servier Announce Positive Clinical Trial Results
Apr 13 2026
NASDAQ.COM
IDEAYA and Servier Announce Positive Results for Darovasertib Clinical Trial
Apr 13 2026
PRnewswire
IDEAYA Biosciences Reports Positive Results for Darovasertib in Clinical Trial
Apr 13 2026
Newsfilter
US-Iran Talks Fail, Oil Prices Surge Above $100
Apr 13 2026
stocktwits
Ideaya Biosciences Set to Release Darovasertib Trial Data
Apr 13 2026
stocktwits
IDEAYA Biosciences to Announce Phase 2/3 Trial Results for Darovasertib
Apr 10 2026
PRnewswire
IDEAYA Biosciences to Announce Phase 2/3 Trial Results
Apr 10 2026
Newsfilter
IDEAYA Biosciences Initiates Clinical Trial for IDE574
Apr 06 2026
PRnewswire
Show More News
